Yifan Pharmaceutical Co., Ltd. (SHE: 002019)

China flag China · Delayed Price · Currency is CNY
10.69
-0.11 (-1.02%)
Feb 6, 2025, 10:30 AM CST
6.69%
Market Cap 13.14B
Revenue (ttm) 5.00B
Net Income (ttm) -331.54M
Shares Out 1.22B
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 26.02
Dividend 0.20 (1.86%)
Ex-Dividend Date Sep 25, 2024
Volume 4,034,400
Average Volume 9,165,831
Open 10.63
Previous Close 10.80
Day's Range 10.61 - 10.82
52-Week Range 9.94 - 14.40
Beta 0.98
RSI 52.18
Earnings Date Apr 28, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinolog... [Read more]

Sector Healthcare
Founded 2000
Employees 4,230
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.